Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Japanese”

2,028 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,028 results

Large-scale testing (Phase 3)Study completedNCT00717860
What this trial is testing

A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)

Who this might be right for
Fungal Infection
Merck Sharp & Dohme LLC 121
Early research (Phase 1)Study completedNCT01000597
What this trial is testing

Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate is Processed by the Body in Healthy Caucasian, Japanese, Korean and Chinese Subjects

Who this might be right for
Asthma
GlaxoSmithKline 80
Large-scale testing (Phase 3)Study completedNCT02203149
What this trial is testing

Study of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Japanese Participants With Chronic Hepatitis C (MK-5172-058)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 399
Large-scale testing (Phase 3)Study completedNCT02911948
What this trial is testing

A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 210
Testing effectiveness (Phase 2)Study completedNCT01528735
What this trial is testing

This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 25
Not applicableStudy completedNCT02431117
What this trial is testing

Non-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Syndrome Aged 6-30

Who this might be right for
Down Syndrome
Chugai Pharmaceutical 43
Early research (Phase 1)Study completedNCT03493386
What this trial is testing

Daprodustat Bioequivalence and Food Effect Study

Who this might be right for
Anaemia
GlaxoSmithKline 64
Early research (Phase 1)Study completedNCT00538174
What this trial is testing

Phase I Multiple-Ascending Dose (Japan)

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 36
Early research (Phase 1)Study completedNCT04427917
What this trial is testing

Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants

Who this might be right for
Healthy
Pfizer 8
Large-scale testing (Phase 3)Study completedNCT05513586
What this trial is testing

Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 15
Early research (Phase 1)Study completedNCT03055962
What this trial is testing

Study to Evaluate the Safety and Tolerability of a Once Daily Dose of 50 mg E2609 in Healthy Japanese Subjects

Who this might be right for
Healthy Participants
Eisai Co., Ltd. 16
Not applicableStudy completedNCT01866761
What this trial is testing

Relationship Analysis Between Periodontal Disease and Atherosclerosis in Japanese Medical Cooperation Services

Who this might be right for
Periodontal DiseaseAtherosclerosis
Okayama University 116
Testing effectiveness (Phase 2)Study completedNCT04477486
What this trial is testing

Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma (MCL)
AbbVie 13
Testing effectiveness (Phase 2)Study completedNCT00540670
What this trial is testing

Study of E5555 in Japanese Subjects With Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Eisai Co., Ltd. 240
Early research (Phase 1)Study completedNCT02537405
What this trial is testing

Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects

Who this might be right for
Embolism, Atrial Fibrillation and Venous Thrombosis
Bayer 40
Early research (Phase 1)Ended earlyNCT04272775
What this trial is testing

MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Relapsed and/or Refractory Multiple Myeloma
Takeda 14
Not applicableStudy completedNCT00708669
What this trial is testing

Japan-Drug Eluting Stents Evaluation; a Randomized Trial

Who this might be right for
Coronary Artery Disease
Associations for Establishment of Evidence in Interventions 3,500
Large-scale testing (Phase 3)Study completedNCT00991146
What this trial is testing

Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase

Who this might be right for
Cryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more
Novartis Pharmaceuticals 19
Large-scale testing (Phase 3)Study completedNCT02094937
What this trial is testing

Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects

Who this might be right for
Asthma
GlaxoSmithKline 430
Not applicableStudy completedNCT00233870
What this trial is testing

A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 405
Load More Results